Sciatica is a specific pain in the lower extremity resulting from the sciatic nerve's irritation due to the sciatic nerve or sciatic nerve root pathology. Sciatica's pain is typically felt from the low-back (lumbar area) to behind the thigh and can radiate down below the knee. It is also an unbearable condition in which the patient experiences pain and/or paresthesia in the supply of the sciatic nerve or linked lumbosacral nerve root. There are some significant risk factors associated with the patient for initiating the disease and further progression. Some of them are personal factors that involve the peak age of the disease occurrence between 45 and 64 years. Smoking and mental health are some of the causes and significant factors for the progression of the disease. Occupational factors such as strenuous physical activity, for example, frequent lifting, especially while bending and twisting, driving, including vibration of the whole body, can also be one of the minor factors. Sciatica Epidemiological Segmentation&nbsp;The Epidemiological Segmentation of Sciatica in 7MM from 2017 to 2030 is segmented as:-&nbsp;<ul><li>Prevalence of Sciatica</li><li>Diagnosed Prevalence of Sciatica</li><li>Cause-specific Diagnosed Prevalence of Sciatica</li><li>Gender-specific Diagnosed Prevalence of Sciatica</li><li>Surgery eligible patient pool</li><li>Age-specific Diagnosed Prevalence of Sciatica</li></ul> <a href="https://www.delveinsight.com/report-store/sciatica-epidemiology-forecast" rel="noopener noreferrer" target="_blank" style="background-color: transparent; color: rgb(0, 71, 178);">Sciatica Epidemiology</a>&nbsp;<ul><li>The total prevalent population of Sciatica in 7MM in 2017 was 27,022,660</li><li>The surgery eligible patient pool in the US in 2017 was 1,082,736&nbsp;&nbsp;</li></ul> <a href="https://www.delveinsight.com/report-store/sciatica-market" rel="noopener noreferrer" target="_blank" style="background-color: transparent; color: rgb(0, 71, 178);">Sciatica Market</a>The market size of Sciatica in 7MM in 2017 was USD 2,047.28 Million Sciatica Market Drivers<ul><li>Survival Rate</li><li>Improved Awareness</li><li>Efficient Pipeline Activity</li><li>Increased Research and Development</li></ul> Sciatica Market Barriers<ul><li>Use of Off Label Therapies</li><li>Fewer Patients</li></ul> <a href="https://www.delveinsight.com/report-store/sciatica-pipeline-insight" rel="noopener noreferrer" target="_blank" style="background-color: transparent; color: rgb(0, 71, 178);">Sciatica Emerging Drugs</a>The emerging drugs of the Sciatica market are&nbsp;<ul><li>SP-102 (Semdexa)</li><li>Hernicore (SI-6603/Condoliase)</li><li>Clonidine Micropellets</li><li>SX600</li><li>KLS-2031</li><li>KTP-001</li></ul>And many others.&nbsp;&nbsp; Sciatica Key PlayersThe key players in the Sciatica market are<ul><li>Scilex Holding Company</li><li>Seikagaku Corporation</li><li>Sollis Therapeutics</li><li>SpineThera</li><li>Kolon Life Science</li><li>Teijin America</li></ul>And many others.&nbsp;

Sciatica Market

Sciatica Symptoms, Treatment, epidemiology, companies, drugs infographic is a short guide to understand the problem and market landscape.